Explores isoflavone biosynthesis in soybean, suggesting molecular targets for enhanced nutritional quality.
Isoflavones are flavonoids with antioxidant and health-promoting properties; however, the genetic basis underlying their accumulation remains unclear. Here, we integrate metabolomic and transcriptomic analyses to investigate isoflavone biosynthesis in two sister soybean lines differing in seed isoflavone content. UPLC-MS/MS reveals that GD10 consistently accumulates higher levels of isoflavone glycosides during late seed maturation. Transcriptomic profiling shows that isoflavone 7-O-glucosyltransferase ( IF7GT3 ) and chalcone isomerase ( CHI4 ) are upregulated in GD10, whereas GD12 exhibits higher expression of flavonol synthase ( FLS1 ) and flavonoid 3′-monooxygenase ( CYP75B1 ), redirecting flux toward competing flavonoid branches. Co-expression network analysis identified 20 transcription factors potentially involved in isoflavone regulation, of which colocalize with previously identified flavonoid QTLs. Hairy-root assays demonstrate that IF7GT3 promotes daidzin accumulation, whereas Y1H and dual-luciferase assays demonstrate that TF_NAC_2 directly binds to the IF7GT3 promoter and activates its expression. These findings provide molecular targets for breeding soybean cultivars with enhanced isoflavone content.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: